A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, ...
It’s been a topsy-turvy week for Novo Nordisk, makers of the popular weight loss drugs Ozempic and Wegovy. Fresh off the heels of a disappointing trial for one experimental drug, the company has just ...
Even a cursory read of the study will likely prompt questions, but let’s take the findings at face value based on what was ...
For many Americans, the weight-loss medications broadly referred to as GLP-1s are transforming the way they think and feel ...
The latest medical science reveals that healthy weight loss doesn't require special genes, diets, or exercise programs. The ...
Retatrutide helped trial participants lose up to 28.7% of their body weight, but experts warn about excessive weight loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results